Boomfish Wealth Group, LLC
Position in ESPR — Esperion Therapeutics, Inc.
CIK 2010786
ALPHARETTA, GA
Position in ESPR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$0
+$0 QoQ
Shares Held
45,306
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Boomfish Wealth Group, LLC holds $15,288 across 2 Drug Manufacturers - Specialty & Generic names. ESPR ranks #2 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRDL |
Cardiol Therapeutics Inc.
|
14,423 | $15,288 | |
| 2 | ESPR |
Esperion Therapeutics, Inc.
This page
|
45,306 | $0 |
All Filings in ESPR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 45,306 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | — | 45,306 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | — | 45,306 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | — | 45,306 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | — | 45,306 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | — | 34,997 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | — | 34,997 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | — | 34,997 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | — | 29,895 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | — | 29,895 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||